Center Laboratories, Inc. (TPEX:4123)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.55
+0.15 (0.40%)
Jul 18, 2025, 1:30 PM CST

Center Laboratories Company Description

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines.

It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells.

In addition, the company engages in drug development, cell therapy, biotechnology, biopharmaceutical, hydrogen energy, and dairy business.

Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.

Center Laboratories, Inc.
CountryTaiwan
Founded1959
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
CEOSu-Chi Wang

Contact Details

Address:
No. 3-2, Building H
Taipei City, 115
Taiwan
Phone886 2 2655 8680
Websitecenterlab.com.tw

Stock Details

Ticker Symbol4123
ExchangeTaipei Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyTWD
ISIN NumberTW0004123005
SIC Code2834

Key Executives

NamePosition
Su-Chi WangChief Executive Officer, Chief Investment Officer, Chief Operating Officer and Chairman
Min-Li LienAssistant Vice President of Legal Affairs Department
Jui-Pao HsuGeneral President of Pharmaceutical Business
Ching-Yu TangHead of Corporate Governance
Chiun-Yu LinPlant Director
An-Ni MaoManager of Finance and Accounting Department
Hsiu Yueh LinDirector of Administration Department